Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological Pharmacokinetic Models: Assumption with Protein Binding
Model Approaches for Pharmacokinetic Data: Physiological Models
Pharmacokinetic Models: Overview
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Miao-Chan Huang1, Julia Macente1, Sofie Heylen1
1Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
一种新的生理学基础的药理动力学 (PBPK) 模型预测肝脏暴露于博森坦,有助于评估肺动脉高血压患者的风险. 这种模型有助于弥合体外和体内数据,以更好地了解波森坦诱导的肝损伤.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: